Cancer diagnostics company Cernostics announced collaboration with the Academic Medical Center in The Netherlands, which will give the Oakland company access to one of the world's biggest Barrett's Esophagus patient registries in the world....
Read more
Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that it is collaborating with the Academic Medical Center in The Netherlands (AMC). As part of t...
Read more
Cernostics said on Tuesday it is collaborating with the Academic Medical Center in the Netherlands to complete validation studies of the company's test for cancer in patients with Barrett's Esophagus....
Read more
Cernostics Inc., which is developing cancer diagnostics, has raised $1.4 million in Series B funding as it advances a test for esophageal cancer. Original investors participating in the round include Geisinger Health System, Novitas Capital an...
Read more
A Pittsburgh-based life sciences company has raised $1.4 million in Series B funding for its work on a next-generation cancer diagnostic tool....
Read more